deltatrials
Completed OBSERVATIONAL NCT00687414

Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders

Sponsor: Community Foundation for Southeast Michigan (JP McCarthy Fund)

Updated 13 times since 2017 Last updated: Jul 26, 2023 Started: Apr 30, 2008 Primary completion: Dec 31, 2009 Completion: Jan 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates AML and MDS and is currently completed. Community Foundation for Southeast Michigan (JP McCarthy Fund) leads this study, which shows 13 recorded versions since 2008 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jan 2023 · 13 months · monthly snapshot~Jan 2023 – ~Aug 2023 · 7 months · monthly snapshot~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshot~Jan 2026 – present · 6 months · monthly snapshot

Change History

13 versions recorded
  1. Jan 2026 — Present [monthly]

    Completed

  2. Sep 2024 — Jan 2026 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Aug 2023 — Jul 2024 [monthly]

    Completed

  5. Jan 2023 — Aug 2023 [monthly]

    Completed

Show 8 earlier versions
  1. Dec 2021 — Jan 2023 [monthly]

    Completed

  2. Jan 2021 — Dec 2021 [monthly]

    Completed

  3. Nov 2020 — Jan 2021 [monthly]

    Completed

  4. Jun 2018 — Nov 2020 [monthly]

    Completed

  5. May 2018 — Jun 2018 [monthly]

    Completed

  6. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  7. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  8. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Community Foundation for Southeast Michigan (JP McCarthy Fund)
  • Corewell Health West
  • Van Andel Research Institute
Data source: Corewell Health West

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations